Table 1 Baseline characteristics of the cohort
Total number of patients | 249 |
|---|---|
Female (%) | 127 (51.0) |
Median age in years (IQR) | 56 (43–67) |
Duration of complaints: | |
- Less than a week (%) | 45 (18.1) |
- Between 1 and 2 weeks (%) | 104 (41.8) |
- Between 2 and 3 weeks (%) | 97 (39.0) |
Comorbidity (%) | 196 (78.7) |
Hospital admission in previous year (%) | 32 (12.9) |
Received influenza vaccination (%) | 108 (43.4) |
Antibiotic usage previous 3 months (%) | |
- None | 121 (48.6) |
- One course | 95 (38.2) |
- More than one course | 33 (13.3) |
Antibiotic courses (%) | |
- Amoxicillin | 48 (29.6) |
- Amoxicillin with clavulanic acid | 7 (4.3) |
- Penicillin | 5 (3.1) |
- Doxycycline | 38 (23.5) |
- Macrolide | 14 (8.6) |
- Quinolone | 3 (1,9) |
- Other | 4 (2.5) |
- Unknown antibiotic | 43 (26.5) |
Smoking (previous or current) (%) | 141 (56,6) |
Median CRB-65 scorea (IQR) | 0 (0–1) |